Manchester City v Bayer Leverkusen
Digest more
The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during the study.
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.
Shares in Bayer jumped more than 8% on Monday after initial clinical trial results turned around the fortunes of a key cardiovascular drug that suffered a major development setback two years ago.
Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.
Manchester City's rotated side fell flat on Pep Guardiola's UEFA Champions League century night, as Bayer Leverkusen struck through Alejandro Grimaldo and Patrik Schick to hand the hosts their first E
German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
Asundexian's Phase 3 study results raise hopes for a new class of cardiovascular drugs that has seen clinical setbacks.
Pep Guardiola admits he may have made too many changes in Manchester City’s 2-0 home defeat to Bayer Leverkusen.The City boss opted to make ten changes to the team which lost to Newcastle as goals
Feedback